|
|
||||||||

*
Bial-Arístegui, Research and Development Department, Bilbao, Spain; and
Hospital Universitario, Facultad de Medicina, Universidad de Murcia, Murcia, Spain
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Very often the sensitization to CR extends to all arthropods (insects, arachnids, and crustaceans) and sometimes also to other invertebrates (17, 18, 19, 20). Tropomyosins are a family of closely related proteins present in muscle and nonmuscle cells and in association with the troponin complex play a central role in the actin-linked calcium regulatory system of muscle contraction (21). Tropomyosins have been described as relevant allergens in extracts from crustaceans, mites, insects, and mollusks (22, 23, 24) and could be involved in the high cross-reactivity found among these organisms (25, 26).
We report here the cloning of the tropomyosin from P. americana and its high level expression in Escherichia coli as a nonfusion protein. Ab binding reactivity of the recombinant allergen was compared with that of its natural counterpart, and recombinant allergen was used for studying the potential pan-allergen behavior of tropomyosins.
| Materials and Methods |
|---|
|
|
|---|
Adult whole bodies of both sexes of P. americana were obtained from Dr. X. Bellés (Centro de Investigación y Desarrollo-Consejo Superior de Investigaciones Científicas, Barcelona, Spain). Atlantic shrimp (Pandalus borealis) was purchased from a local seafood store. Whole bodies of CR and peeled shrimp tails were snap-frozen, ground in a mortar, and conserved at -20°C until used. Preparation of acetone powder from CR and shrimp tails was performed as described by Smillie (21). Purification of tropomyosin from acetone powder was conducted by a modification of the isoelectric precipitation method (21). Briefly, 5 g of acetone powder was incubated in 50 ml of extraction buffer (1 M KCl and 0.5 mM DTT, pH 7.0) for 16 h at room temperature, and centrifuged at 5000 x g for 15 min. The precipitate was extracted one more time for 2 h. The pooled supernatants were cooled to 4°C, adjusted to pH 4.6, and stirred for 30 min. After centrifugation at the above conditions, the precipitate was dissolved in extraction buffer and centrifuged again. This isoelectric precipitation at pH 4.6 and dissolution of the precipitate in extraction buffer at pH 7.0 were repeated twice, the final precipitate was dissolved in 0.5 mM DTT, pH 7.0, and dialyzed against PBS. Further purification was obtained after precipitation with 3560% ammonium sulfate saturation. The purified protein solution was dialyzed against 0.1x PBS and stored at -20°C. In a typical preparation, 13 mg of purified tropomyosin (0.08% yield) were obtained from 16 g of CR bodies, and 99 mg of purified tropomyosin (0.16% yield) were obtained from 61 g of shrimp tails.
Cloning of tropomyosin cDNA by PCR amplification
Poly(A)+-enriched mRNA was isolated from 100 mg of P. americana using the Quick Prep MicroRNA Purification Kit (Pharmacia, Uppsala, Sweden). First-strand cDNA was synthesized from 1 µg of poly(A)+-enriched mRNA using a first-strand synthesis kit (Pharmacia) and random hexadeoxynucleotides as primers. Degenerate oligodeoxynucleotide primers (Cruachem, Glasgow, U.K.) for cDNA amplification were designed according to previously reported invertebrate tropomyosin sequences (22, 27, 28, 29). The primers used were: TROF, 5'-CCGGGATCCCATATGGA(G/T)GC(C/T)ATCAAGAA(A/G)AA (sense); and TROR, 5'-CCGAATTCT(T/C)A(A/G)TA(G/A/T)ACCAG(T/A/C)(A/C)A(G/A)(T/C)TCGG (antisense), where the slash between bases means that they were added at that particular position in equimolecular amounts during the synthesis of the primer. BamHI, NdeI, and EcoRI restriction sites are underlined. Five microliters of the single-stranded cDNA were mixed with the described degenerate primers in standard PCR mixture and subjected to amplification with Taq DNA polymerase (Bioline, London, U.K.) in the following conditions. After denaturation at 94°C for 4 min, the sample was subjected to five cycles at 94°C for 1 min, 45°C for 2 min, and 72°C for 2 min, followed by 30 cycles at 94°C for 1 min, 56°C for 2 min, and 72°C for 2 min, and a final incubation at 72°C. A predominant band of about 870 bp was isolated from 1% agarose gels (GeneClean, BIO 101, La Jolla, CA). After an initial denaturation step at 94°C for 4 min, the cDNA fragment was reamplified with 30 cycles at 94°C for 1 min, 56°C for 2 min, and 72°C for 2 min and a final incubation at 72°C for 6 min. The fragment was isolated from the gel and ligated to the pGEM-T vector (Promega, Madison, WI), and the resulting construction was designated pTP1. Recombinant DNA techniques were performed by standard methods (30).
Nucleotide sequencing
Nucleotide sequences were determined using the ABI PRISM Dye Terminator Cycle Sequencing Ready reaction kit and run on an ABI 373A DNA sequencer (both from Perkin-Elmer, Foster City, CA). Commercial and sequence-based primers were used. The analysis of the sequences was achieved using the GCG Program Package (Genetics Computer Group, Madison, WI) and the BLAST program (31).
Expression and purification of recombinant tropomyosin
Tropomyosin-encoding cDNA was cloned into the expression vector pKN172 (32) and expressed in E. coli BL21 (DE3) carrying the lacUV5 promoter and the gene for the T7 RNA polymerase (33). The lacUV5 promoter, induced by isopropyl-thio-ß-galactoside (IPTG), directs transcription of the T7 RNA polymerase, which, in turn, transcribes target DNA cloned under control of the T7 promoter. Tropomyosin-encoding cDNA was transferred from pTP1 to pKN172 as a NdeI-EcoRI fragment. Competent E. coli BL21 (DE3) cells were transformed with the resulting construction. The cells were grown to an OD600 of 0.6 in Luria Bertani broth containing 200 µg/ml ampicillin. Isopropyl-thio-ß-galactoside was then added to a final concentration of 0.6 mM, and incubation was continued for another 3 h. Cells were harvested by centrifugation, and the pellet was resuspended in 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, and 1 mM EDTA containing 100 µg/ml lysozyme and incubated for 15 min at 37°C. After mild sonication (six pulses of 10 s each), the recombinant tropomyosin was purified by a modification of the isoelectric precipitation method of Smillie (21) as described above.
Human and experimental sera
Twenty-nine household insect-allergic patients from economically depressed areas of Marseille, France (9 woman and 20 men; mean age, 32 yr; range, 662 yr) were selected. Patients suffered from asthma (19), allergic rhinitis (6), spasmodic cough (2), conjunctivitis (1), or atopic dermatitis (1). All of them demonstrated more than a class 1 score of serum-specific IgE to P. americana measured by the Hy-Tec specific IgE enzyme immunoassay (Hycor Biomedical, Irvine, CA), and positive skin prick test. A pool of sera from seafood allergic patients with a class 2 score of serum-specific IgE to shrimp was also used. Experimental and commercial rabbit polyclonal Abs against tropomyosins were employed to characterize recombinant protein. For the elaboration of experimental immunosera, immunization was performed in adult male White New Zealand rabbits and Swiss mice. Weekly injections of 20 µg of purified shrimp tropomyosin or 100 µg of purified CR tropomyosin, both with CFA, were given s.c., and after eight injections the animals were bled, and the serum was collected. Commercial immunosera against chicken tropomyosin were purchased from Sigma (St. Louis, MO).
Analytical methods
Determination of the protein concentration was performed according to the method of Bradford (34). Proteins were analyzed by SDS-PAGE under reducing conditions (35) and visualized by Coomassie Brilliant Blue R-250 (36). For immunoblotting experiments, proteins after SDS-PAGE were electrophoretically transferred to polyvinylene difluoride (PVDF) membranes (Immobilon-P, Millipore, Bedford, MA) (37). Membranes were incubated overnight at 4°C with allergic patient serum or at 37°C for 60 min with rabbit polyclonal serum against shrimp or chicken tropomyosin (diluted 1/1000 or 1/50, respectively). Immunodetection was performed as previously described using anti-rabbit IgG, anti-mouse IgG, or anti-human IgE Abs linked to horseradish peroxidase (38). Image analysis was performed using the Bio-Image system (Millipore). The shrimp tropomyosin used for immunization was isolated from shrimp extract by electroelution. Briefly, following SDS-PAGE, the gel was stained for a short period, just long enough to outline the bands, and the tropomyosin band (36 kDa) was cut, minced, placed in an elution tube, and eluted with a Bio-Rad model 422 electroeluter (Bio-Rad, Hercules, CA) at 10 mA/tube over 4 h.
Inhibition assays
For ELISA inhibition assays, microtiter plates (A/S, Nunc, Roskilde, Denmark) were coated with 200 ng/well of natural tropomyosins in 0.1 M bicarbonate buffer, pH 9.6, and blocked with blocking buffer (PBS supplemented with 0.05% Tween-20 and 1% BSA). One hundred-microliter aliquots of rabbit anti-shrimp (diluted 1/2500) or mice anti-CR (diluted 1/5000) tropomyosin serum or serum from allergic patients (diluted 1/2 or 1/4), previously incubated with different concentrations of natural and recombinant tropomyosins, were subsequently added and incubated for 1 h at 37°C. For immunoblot-inhibition studies, serum from household insect-allergic patients was incubated overnight at 4°C with 20 µg of purified inhibitor or BSA (negative control)/ml of sera. The preadsorbed sera were then used for immunoblot experiments.
| Results |
|---|
|
|
|---|
RT-PCR conducted on P. americana mRNA with the
above-mentioned primers produced a single fragment of approximately 850
bp, which was cloned into pGEM-T and sequenced (Fig. 1
).
The sequence encoded a polypeptide of 284 amino acids with a predicted
molecular mass of 32,776 Da and a pI of 4.69. No potential
N-linked glycosylation sites (NXT/S) were identified. A
periodic heptameric sequence constituting the
-helical turn and an
extensive leucine zipper motif, both characteristic of tropomyosins,
occur throughout the sequence. Sequence similarity searches using the
BLAST program revealed that P. americana tropomyosin has the
highest homology to insect tropomyosins from Locusta
migratoria (89%) and Drosophila melanogaster (84%;
Fig. 2
). High homologies were also found in other
arthropods such as crustaceans (shrimp, 8481%) and arachnides
(mites, 80%). The homology to other invertebrate tropomyosins
decreased outside the phylum Arthropoda, i.e., nematodes (69%) or
mollusks (69%) (22, 27, 28, 29, 39, 40, 41). Significant, but lower, homology
was also found with vertebrate tropomyosins, including human (54%
identity, 74% similarity). P. americana tropomyosin was
designated Per a 7 in accordance with the International Union of
Immunological Societies allergen nomenclature subcommittee (42).
|
|
Natural P. americana tropomyosin was purified from
whole body CR extract by isoelectric precipitation and ammonium sulfate
fractionation. The protein gave a single homogeneous band on Coomassie
blue-stained SDS-PAGE, with an apparent molecular mass of 37.1 kDa
(Fig. 3
A). The yield of natural allergen from
CR extracts was 0.7% (w/w). Recombinant P. americana
tropomyosin was expressed as a nonfusion protein in E. coli
BL21 (DE3), using the pKN172 vector system, and purified by isoelectric
precipitation and ammonium sulfate fractionation. Repeated extraction
of the first precipitate was necessary for improving Per a 7 recovery.
The pure protein migrated as a 37.6-kDa band on SDS-PAGE (Fig. 3
A). The yield of purified rPer a 7 was 9 mg/l of bacterial
culture. In the presence of 6 M urea the mobility of tropomyosins from
different sources is reduced compared with that of other proteins. This
criteria was used to assess the identity and purity of tropomyosin
preparations (21). The mobility of purified P. americana
tropomyosins (natural and recombinant forms) indeed changed on SDS-PAGE
containing 6 M urea, giving apparent molecular masses of 52 and 47.8
kDa, respectively, whereas BSA (67 kDa) and cytochrome c
(12.5 kDa) migrated at the expected positions (Fig. 3
B).
|
The reactivity of natural and recombinant P. americana
tropomyosins is higher to IgG rabbit Abs against shrimp tropomyosin
than it is to those against chicken tropomyosin, as could be expected
on the basis of amino acid homology (84% for shrimp and 54% for
chicken tropomyosins; data not shown). The IgG binding specificity of
natural and recombinant CR tropomyosins was assessed by
ELISA-inhibition using CR tropomyosin-coated plates and antisera
against CR and shrimp tropomyosins. Recombinant Per a 7 was able to
inhibit IgG binding to natural tropomyosin up to 45% when sera against
CR tropomyosin was used, while natural CR tropomyosin produced an
inhibition of 95% (Fig. 4
). Similar inhibition was
found when ELISA-inhibition experiments were performed with sera
against shrimp tropomyosin. No significant effect was detected when BSA
was used as inhibitor. These results confirm that some epitopes from
the natural tropomyosin are not present in its recombinant counterpart.
The frequency of IgE binding to tropomyosin (from the extract and the
purified recombinant protein) was compared by immunoblotting.
IgE-reacting Abs to the purified tropomyosin were detected in 12 of 29
sera tested (41%). A representative Western blot including
tropomyosin-positive sera is shown in Fig. 5
. Seven of
these sera gave a strong signal in the 37-kDa band, which was weaker in
the other five sera. The former sera also reacted to bands of 33, 29,
21, and 18 kDa (probably tropomyosin degradation fragments) as well as
to a 80-kDa band, which could be a dimeric form of the tropomyosin
(Fig. 5
B). These tropomyosin-positive sera also reacted with
a 37-kDa band from the CR extract. Regardless of their reactivity to
the 37-kDa band, almost all the sera in the CR extract reacted to a
40-kDa band (Fig. 5
A).
|
|
Inhibition experiments of IgE reactivities of
tropomyosin-sensitive patients to other arthropod extracts by Per a 7
demonstrated that tropomyosins are important allergens in these
species. Immunoblotting-inhibition experiments showed that both Per a 7
(natural and recombinant forms) were able to inhibit IgE binding to
tropomyosin in P. americana and Blatta
orientalis, and Blatella germanica extracts (Fig. 6
). It is important to notice that almost all the
IgE-binding bands (65, 52, 36, 27, and 20 kDa) detected in B.
orientalis extract disappeared in the presence of tropomyosin.
These IgE-reacting bands different from tropomyosin could be produced
by tropomyosin aggregation or degradation processes. Nevertheless,
natural tropomyosin produced stronger inhibition than the recombinant
counterpart. When sera from seafood-allergic patients were used, both
Per a 7 allergens (natural and recombinant forms) produced similar
inhibition. The homologous allergen, shrimp tropomyosin, and Per a 7
also blocked IgE reactivity to the other allergens detected by the
tested sera (Fig. 6
C). In ELISA-inhibition experiments, Per
a 7 allergens produced 50% inhibition of IgE binding to shrimp
tropomyosin compared with 96% inhibition produced with shrimp
tropomyosin (Fig. 7
). This finding indicated that some
common epitopes are present in these two tropomyosins.
|
|
| Discussion |
|---|
|
|
|---|
-helical coiled structure along their entire length, which lent
these particular migrating properties.
The IgG and IgE binding capacities of the recombinant tropomyosin
were weaker than those of the natural protein, as rPer a 7 is able to
inhibit IgG binding to natural CR tropomyosin to only 50%, using
experimental sera against CR tropomyosin and against shrimp tropomyosin
as well. It is not unusual that a recombinant protein produced in
prokaryotic cells has less biological activity than that of their
natural counterpart (22). This fact could be due to improper folding of
the recombinant protein produced in E. coli or to the
existence of various isoforms of tropomyosin involved in the allergenic
response. The production of the recombinant allergen in a more
convenient host-vector system, such as insect cells using
baculovirus-derived vectors, could solve the problems related to the
improper folding of the expressed protein. On the other hand, the
existence of distinct tropomyosin isoforms found in muscle, brain, or
nonmuscle cells is well known (45). We suppose that Per a 7, prepared
in our laboratory, is one of the various tropomyosin isoforms present,
which has some epitopes in common with the natural tropomyosins
isoforms used for producing experimental sera, or with the tropomyosin
isoforms that induce allergy. It is interesting to notice that in
ELISA-inhibition experiments using sera from seafood allergic patients,
both natural tropomyosin and rPer a 7 produced similar inhibition (Fig. 7
). This effect that could indicate differences in the epitopes
recognized by IgG and IgE Abs should be investigated in more detail.
Cross-reactivity between CR has been previously reported (11, 46), but
analyses using cloned or purified CR allergens have shown that to date
only Per a 1 and Bla g 1 share significant homology and antigenic
cross-reactivity (4, 11, 12). B. germanica allergens Bla g
2, Bla g 4, and Bla g 5 are not present in P. americana
extracts (6, 7, 8), and Per a 3 from P. americana is not
detected in B. germanica (14). The Western blotting
inhibition experiments described here showed that Per a 7 is the second
cross-reacting allergen described in CR, as it is present in the two CR
species tested (B. germanica and B. orientalis).
It is interesting to notice that a doublet band of 36 and 40 kDa
appeared in most of the patients sera (Fig. 5
), but with different
intensities. This doublet was already detected at a frequency of 58.3%
in sera from 12 atopic patients (10). This double band also appeared in
extracts from other CR and shrimp extracts (Fig. 6
), but in these cases
the IgE reactivity of the larger component was inhibited by natural and
recombinant CR tropomyosin, in contrast to that in the P.
americana extract. Experiments involving isolation of this
reactive protein are now in progress to understand these unexpected
results. Preabsortion with tropomyosins removed IgE reactivity against
other IgE-reactive bands in B. orientalis and P.
borealis. This fact, reported previously in mollusca and crustacea
extracts (18) could be due to the specific inhibitory effect to other
tropomyosin isoforms, tropomyosin aggregates/degradation products, or
other proteins that share common reactive epitopes with tropomyosin.
IgE-reacting bands of 3640 kDa, identified as tropomyosins, have been
found in extracts from organisms such as crustaceans, insects, and
mollusks, but not in vertebrates (chicken or mouse) (18, 25, 26, 47).
Some of these species, belonging to the crustacean and mollusk groups,
are important food sources in many parts of the world. The existence of
cross-reactivity among these species may be explained by the close
phylogenetic relationship between these Phyla, although different
epitopes must exist among their tropomyosins, since Per a 7 could only
produce a 50% inhibition of IgE binding to shrimp tropomyosin, while
this protein produced a 95% inhibition (Fig. 7
). Nevertheless,
serological IgE reactivity does not always result in a clinical
hypersensitivity reaction, thus rigorous clinical studies of the
hypersensitivity reaction to different invertebrates should be
performed among patients positive for tropomyosin. Recent works on
shrimp tropomyosins reported six IgE-reactive peptides (24, 29) that
showed different degrees of identity to the Per a 7 sequence. The
sequence of the peptides E2, E3, and E6, obtained from Penaeus
aztecus (brown shrimp) tropomyosin (Pen a 1), are highly
homologous to Per a 7, with 100, 92, and 92% identical residues. The
sequences of the peptides P6 and P9 from Penaeus indicus
(Indian shrimp) tropomyosin have also high similarity, with 77 and 63%
identical residues. The lack of allergenic cross-reactivity with
tropomyosins from vertebrate sources suggests that some residues among
these peptides may be the critical amino acids involved in binding to
IgE. For example, the identities of P9, E4, and E3 to the corresponding
regions of human tropomyosin are 30, 30, and 50%, respectively.
In conclusion, this paper described the primary structure of an allergenic tropomyosin from a previously unreported source and demonstrated that the heterologous expression system and purification procedures used are suitable for the production in high amounts of well-characterized and purified recombinant Per a 7. This recombinant allergen could allow more detailed immunological characterization of tropomyosins and establish the role of these proteins in the cross-reactivity among invertebrates.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Juan A. Asturias, Bial-Arístegui, Research and Development Department, Alameda Urquijo 27, E-48008 Bilbao, Spain. E-mail address: ![]()
3 Abbreviations used in this paper: CR, cockroach(es); pI, isoelectric point; PVDF, polyvinylene difluoride; Per a 7, Periplaneta americana allergen 7; GST, glutathione S-transferase. ![]()
Received for publication July 23, 1998. Accepted for publication January 8, 1999.
| References |
|---|
|
|
|---|
and ß tropomyosins. Methods Enzymol. 85:234.
This article has been cited by other articles:
![]() |
G. Reese, J. Viebranz, S. M. Leong-Kee, M. Plante, I. Lauer, S. Randow, M. S.-M. Moncin, R. Ayuso, S. B. Lehrer, and S. Vieths Reduced Allergenic Potency of VR9-1, a Mutant of the Major Shrimp Allergen Pen a 1 (Tropomyosin) J. Immunol., December 15, 2005; 175(12): 8354 - 8364. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hooper and J. B. Thuma Invertebrate Muscles: Muscle Specific Genes and Proteins Physiol Rev, July 1, 2005; 85(3): 1001 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Jeong, H. Hwang, J. Lee, I.-Y. Lee, D. S. Kim, C.-S. Hong, H.-I. Ree, and T.-S. Yong Allergenic Characterization of Tropomyosin from the Dusky Brown Cockroach, Periplaneta fuliginosa Clin. Vaccine Immunol., July 1, 2004; 11(4): 680 - 685. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |